Kang, Yu Mi <br/><br/>
Effectiveness and Safety of Adding Basal Insulin Glargine in Patients with Type 2 Diabetes Mellitus Exhibiting Inadequate Response to Metformin and DPP-4 Inhibitors with or without Sulfonylurea.  [electronic resource] 

 -  Diabetes & metabolism journal  08 2019 
 - 432-446 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2233-6079 
<br/><br/><label>Standard No.: </label>10.4093/dmj.2018.0092  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Blood Glucose--analysis<br/>Body Weight--drug effects<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Dipeptidyl-Peptidase IV Inhibitors--adverse effects<br/>Drug Therapy, Combination<br/>Female<br/>Glycated Hemoglobin--analysis<br/>Humans<br/>Hypoglycemia--chemically induced<br/>Hypoglycemic Agents--adverse effects<br/>Insulin Glargine--adverse effects<br/>Male<br/>Metformin--adverse effects<br/>Middle Aged<br/>Sulfonylurea Compounds--adverse effects<br/>Treatment Outcome